Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT04861805Not ApplicableRecruiting

Pivotal Study of the Vienna Transcatheter Self Expandable Aortic Valve SE System

Role: lead

NCT06137807Not ApplicableRecruiting

TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation (TRICAV-I)

Role: collaborator

NCT05114850Recruiting

Retrospective Prospective Multicentric Clinical Follow up of Patients After Being Treated With TricValve®

Role: lead

NCT05871983Not ApplicableNot Yet Recruiting

Munich Transcatheter Mitral Valve Safety and Effectiveness

Role: lead

NCT04141137Not ApplicableCompleted

TRICUS STUDY Euro - Safety and Efficacy of the TricValve® Device

Role: lead

NCT03723239Not ApplicableCompleted

TRICUS STUDY - Safety and Efficacy of the TricValve® Device

Role: lead

All 6 trials loaded